Paul Blanchfield
Patrimonio netto: 7 M $ in data 31/08/2026
Patrimonio netto: 7 M $ in data 31/08/2026
Paul Blanchfield is Chief Executive Officer & Director at Alpha-9 Oncology, Inc. since 2025.
Former roles include President at Lantheus Holdings, Inc. from 2023 to 2025, General Manager-Nordic Baltics at Shire Plc, and Head-US Immunology Business Unit at Takeda Pharmaceutical Co., Ltd. Education includes undergraduate studies at Duke University and graduate and MBA degrees from Stanford University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 17/08/2026 | 69.426 ( 0,11% ) | 7 M $ | 31/08/2026 |
| Società | Posizione | Inizio |
|---|---|---|
Alpha-9 Oncology, Inc.
Alpha-9 Oncology, Inc. BiotechnologyHealth Technology Engages in research clinical stage radiopharmaceutical and drug design for cancer treatment | Amministratore Delegato | 10/11/2025 |
| Società | Posizione | Fine |
|---|---|---|
| LANTHEUS HOLDINGS, INC. | Presidente | 07/11/2025 |
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Develops, manufactures and markets pharmaceuticals | Corporate Officer/Principal | - |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 6 |
|---|---|
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Develops, manufactures and markets pharmaceuticals | Commercial Services |
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Takeda Pharmaceutical Co., Ltd.
Takeda Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research, development, manufacturing and marketing of pharmaceutical products | Health Technology |
Lantheus Holdings, Inc.
Lantheus Holdings, Inc. Medical SpecialtiesHealth Technology Manufactures, markets, sells and distributes medical imaging products | Health Technology |
Alpha-9 Oncology, Inc.
Alpha-9 Oncology, Inc. BiotechnologyHealth Technology Engages in research clinical stage radiopharmaceutical and drug design for cancer treatment | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale